Ex-Vivo Therapeutic Assessments on Patient Derived Organotypic Tumor Spheroids
-
-
-
-
-
-
-
- Xsphera procures qualified patient tumor samples for the study from its clinical site network
- Immune profiling is performed on each patient sample
- Post-treatment assessments include: cytotoxicity, cytokine expression, and gene expression
- The number of study arms can range from 2 to greater than 10 per patient sample
- Murine tumors or human cancer cell lines can be studied instead of patient tumor tissue
-
-
-
-
-
-
Human Tumor Target Expression
-
-
-
-
-
-
-
- Assess proprietary target expression levels on specified patient populations
-
-
-
-
-
-